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This article investigates whether there is an association between the
rs266729 polymorphism in adiponectin promoter gene with meta-
bolic parameters and disease status in 300 type 2 diabetes patients
and 300 healthy adults from Jahrom city, Iran. The variants (G/C)
were tested by polymerase chain reaction-restriction fragment length
polymorphism method (RFLP) and metabolic parameters (glucose,
cholesterol, HDL and LDL cholesterol) were measured using bio-
chemical methods. However, no differences were detected between
the haplotypes investigated, and the data obtained from our lab
shown association of the ADIPOQ promoter polymorphism neither
with biochemical parameters, nor with disease status.
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Value of the data
 We evaluated the association one of the adiponectin gene polymorphisms with diabetes type 2.
 This data is useful for characterising the relationship between heritable traits and the
polymorphism.
 Our data can provide insight into methodology and considerations for investigation of poly-
morphisms in non-coding regions.1. Data
We investigated the potential association between the ADIPOQ gene polymorphism and metabolic
parameters in type 2 diabetic patients. The clinical data and baseline characteristics of the partici-
pants are shown in Table 1. The frequency distribution of genotypes (G/C) rs266729 polymorphism in
healthy subjects and patients is given in Table 2. As GG mutant genotype frequencies between the
two groups of diabetic patients and healthy, as well as the frequency of the G allele showed no
signiﬁcant difference between the groups (PZ0.05). The relationship between the compositions of
the CC genotype against GCþGG with biochemical factors in both patients and controls were eval-
uated. As shown in Table 3. No signiﬁcant relationship was observed between biochemical factors and
this polymorphism (PZ0.05).2. Experimental design, materials and methods
2.1. Characteristics of patients
A cross sectional study was conducted and samples were determined using statistical calculations.
All participants were in the Fars area and Composition of the population in this area is rare. This
research conforms to the declaration of Helsinki and approved by the ethics research committee of
Jahrom University of Medical Sciences. Each participants had consent to partake in the study and,
based on the testimonial, they could leave the study. This study was approved by the Research Ethics
Committee of Jahrom University of Medical Sciences.2.2. Biochemistry tests
People lipid proﬁle (glucose, triglycerides, LDL and HDL) were measure enzymatically using bio-
chemical kits (Pars Azmoon, Iran).
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3–5 ml of venous blood was taken from each of the subjects after 12 h of fasting. DNA was
extracted from nucleated blood cells, according to the DNA extraction protocol kit (cinagenne
Co., Iran).
Sequence of ADIPOQ gene containing the polymorphism was ampliﬁed, using a PCR method with
speciﬁc primers F: 50_ GGTGGACTTGACTTTACTGG -30 and R: 50_ TAGAAGCAGCCTGGAGAA -30 [1]. PCR
reactions were performed in tubes 0.2 ml of PCR Premix (Bioneer, Daejeon, Korea). PCR program were
as follows: 94 °C for 5 min, with 35 cycles of 94 °C for 30 s, 55 °C for 30 s, and 72 °C for one min and
ﬁnal extension 72 °C for 10 min. PCR products (10 μl) of ADIPOQ gene were digested in a 20-μl
reaction volume for 24 with 1.5 U of HhaI at 37 °C (Fermentase Co, Germany). The digested PCR
product was separated on 2% agarose gel and analyzed using G:Box transilluminator System
(Syngene, Frederik,MD, USA). The HhaI product G allele yielded fragments of 212 and 122 bp;
C allele, 334 bp (Fig. 1). Statistical analyses were carried out using commercial available software
(SPSSv.20.0package, IBM, Chicago, IL).Acknowledgements
Funding for the study was provided by the Jahrom University of Medical Sciences and we would
like to thank the research lab in this University of Medical Sciences for long term cooperation.Transparency document. Supplementary material
Transparency data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2016.11.040.Appendix A. Supplementary material
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2016.11.040.Reference
[1] L. Kohan, F. Mohammadi, M. Mohammadian Panah, Association of the -11377 Adiponectin Gene Polymorphism with the
risk of postmenopausal breast cancer, Genetics in the 3rd millennium, vol. 11(3), 2013, pp. 3166–3171.
